This is a service of EIN News a digital news provider
Pharmaceutical Industry Today
Sign up for a free trial
Register Now
Member center Log In
Lantus News is an EIN News Service for pharmaceuticals professionals. Constantly updated news and information about pharmaceuticals.
FORMATS: RSS | EMAIL

Latest Lantus News

Sort by: relevance (24 hours) relevance date
  • Drugs Can Help Treat Diabetes 6 Nov 2009 19:17 GMT
    ... but it can be handled with proper treatment. If diabetes goes untreated, it can cause ... especially in adult-onset Type 2, but new drugs can also aid the treatment. This is ... the injection site, as well as hypoglycemia. Lantus.com also warns that serious allergic reactions may ...

  • Reportlinker Adds Commercial Insight: Antidiabetics in Australia - Reimbursement status shapes novel classes 3 Nov 2009 17:11 GMT
    ... 2009 58 Table 7: Actos (pioglitazone) - Drug profile, 2009 60 Table 8: Impacting factors ... Byetta, Januvia and Actos 95 Table 16: Lantus (insulin glargine) - Drug profile, 2009 97 ... two insulin injection regimens 52 Figure 14: Treatment tree as recommended by the 2008/09 edition ...

  • Reportlinker Adds Commercial Insight: Antidiabetics in Australia - Reimbursement status shapes novel 3 Nov 2009 17:16 GMT
    ... 2009 58 Table 7: Actos (pioglitazone) - Drug profile, 2009 60 Table 8: Impacting factors ... Byetta, Januvia and Actos 95 Table 16: Lantus (insulin glargine) - Drug profile, 2009 97 ... two insulin injection regimens 52 Figure 14: Treatment tree as recommended by the 2008/09 edition ...

  • Sanofi-aventis Delivers a Solid Performance in Third Quarter 2009 30 Oct 2009 12:31 GMT
    ... In the first nine months of 2009, sanofi-aventis generated ... novel oral first-in-class insulin sensitizer for the treatment of type 2 diabetes. As a sensitizer, ... regarding whether and when to approve any drug, device or biological application that may be ...

  • Sanofi-Aventis raised forecast on swine flu vaccines 30 Oct 2009 09:53 GMT
    ... estimate of around 10 percent, France’s largest drugmaker said, according to Bloomberg. The company expects ... analysts. Double-digit sales growth of diabetes drug Lantus and blood thinner Lovenox helped offset a ... a steep drop in sales of cancer treatment Eloxatin, which were hit by generics competition. ...

  • Sanofi-Aventis ups guidance on swine-flu vaccine 30 Oct 2009 10:30 GMT
    ... charges against intangible assets, impairment losses on drugs Benzaclin, Nasacort and Actonel, and deferred taxes, and ... grew 21%. Net sales for the firm's pharmaceuticals business rose 7.6% to 6.35 billion euros, ... euros, led by strong performance of the Lantus and Lovenox drugs. Sales of the Lantus ...

  • Sanofi - Aventis says strong swine flu vaccine sales in 4th quarter will drive higher earnings 30 Oct 2009 08:11 GMT
    ... revenue that grew 8 percent to euro7.4 billion. Demand for its widely prescribed anti-clotting drug Lovenox and diabetes treatment Lantus set a strong pace for Sanofi-Aventis' overall pharmaceutical sales in the quarter. That perfomance ...

  • Sanofi-Aventis Lifts Outlook On Vaccine Sales 30 Oct 2009 08:18 GMT
    ... revenue that grew 8 percent to euro7.4 billion. Demand for its widely prescribed anti-clotting drug Lovenox and diabetes treatment Lantus set a strong pace for Sanofi-Aventis' overall pharmaceutical sales in the quarter. That perfomance ...

  • Strong earnings growth for Sanofi 30 Oct 2009 08:07 GMT
    ... Sanofi-Aventis is the latest drugmaker to raise its full-year forecast on the ... billion euros. Sanofi’s biggest-seller was the diabetes treatment Lantus (insulin glargine), which enjoyed a rise of ...

  • Shrugging Off the Side Effects 30 Oct 2009 20:42 GMT
    ... In addition to managing the Lantus news quite well, Sanofi managed a pretty ... one to worry about is Lovenox. The drug lost patent protection in the U.S. a while ... U.S. a while ago after and Amphastar Pharmaceuticals challenged the patent. But the drug remains ...

  • UPDATE 1-Sanofi lifts forecast thanks to swine flu vaccines 30 Oct 2009 06:44 GMT
    ... generics was offset by growth in other drugs. Sanofi expected H1N1 vaccines to add about $500 ... growth, pulled by anti-thrombosis drug Lovenox, insulin Lantus, as well as vaccines, was partly held ... such as generic drugmakers in Latin America, biotech company Shantha and the buy-out of animal ...

  • Sanofi lifts forecast on swine flu vaccine 30 Oct 2009 10:52 GMT
    ... was offset by revenue growth for other drugs. Sanofi expected H1N1 vaccines to add about ... billion rather than 7.44 billion. Swine flu treatments have boosted growth for several drugmakers. ) ... growth, pulled by anti-thrombosis drug Lovenox, insulin Lantus, as well as vaccines, was partly held ...

  • Sanofi-Aventis is feeling benefits of swine flu jabs 30 Oct 2009 09:32 GMT
    ... Drugmaker Sanofi-Aventis today followed in the footsteps of ... up by anti-thrombosis drug Lovenox and diabetes treatment Lantus, as well as vaccines. But generic competition ...

  • Shire down as swine flu victims flee to rivals 30 Oct 2009 13:53 GMT
    ... Britain's number three drugmaker Shire posted a 14% fall in revenue ... up by anti-thrombosis drug Lovenox and diabetes treatment Lantus, as well as vaccines. But generic competition ...

  • Sanofi-Aventis sees third-quarter profits rise 7.7 per cent 30 Oct 2009 10:45 GMT
    ... Paris - French pharmaceuticals giant Sanofi-Aventis said Friday that its net ... were led by the sales of its insulin brand Lantus, which rose by more than 20 per cent, ...


1 - 15 / 51      NEXT >>>

Powered by Newsfeed Maker
NOT SATISFIED WITH THIS LANTUS NEWS SECTION? MAKE YOUR OWN WITH THE INBOX ROBOT OR TRY OUR OTHER MEDIA MONITORING SERVICES.
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>>
 
 

Take This Poll

According to the White House, 650,000 jobs were created or saved by $150 billion in stimulus funds. Was it money well spent? (Oct. 30, 2009)



 

BUSINESS PROMOTION SERVICES

EIN Advertising · Place banner ads on EIN News industry specific publications.

EIN Presswire · Upload press releases to the EIN network and have them submitted to leading journalists and decision-makers worldwide.

EIN Global Events · Reach industry-specific readers and promote events, conferences or exhibitions.

EIN Business Directory · Present company or service information on highly-visible, industry and geo-specific news pages.

NEWS SERVICES

News Publications · In-depth geopolitical and industry specific news coverage aggregated from 35,000 online outlets. Updated every 15 minutes.

News Alerts · Receive a free selection of the day's top stories hand picked by EIN News editors.

Newsfeed Maker · Integrate customized newsfeeds in any format covering all industry and geopolitical topics, updated every 15 minutes.

EIN Presswire · Upload press releases to the EIN network and have them submitted journalists and decision-makers worldwide.

Inbox Robot · Customized newsletters delivered by e-mail. Search a news index monitoring thousands of trusted media sources.

COMPANY BACKGROUND

About EIN News · Established in 1995, EIN News began by supplying business professionals and individuals with relevant and interesting news products. It has grown to become the largest digital news provider in Europe.

Member List · See the partial member list and join a community of professionals from private industry, institutions, and governments that rely on EIN as a critical source for research, breaking news and media services.